Astley-Sparke Philip
Director
CIK: 1376491
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | enGene Therapeutics Inc. (ENGN) | A | 31,000 | $0.00 | $0.00 | View Details Filing |
| May 18, 2026 | Replimune Group, Inc. (REPL) | S | 17,657 | $5.08 | $89,697.56 | View Details Filing |
3 more transactions available โ create a free account to see 12 months of history | ||||||